<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
	<channel rdf:about="http://www.mdpi.com/rss/special_issue/ecsoc-13">
		<title>Molecules: ECSOC-13</title>
		<link>http://www.mdpi.com/journal/molecules/special_issues/ecsoc-13/</link>
		<description>{snippet name="submission_info"}</description>
								<items>
			<rdf:Seq>
							<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/15/12/8973/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/15/6/4283/" />
            				<rdf:li rdf:resource="http://www.mdpi.com/1420-3049/15/3/1213/" />
                    	</rdf:Seq>
		</items>
				<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
	</channel>
	<item rdf:about="http://www.mdpi.com/1420-3049/15/12/8973/">
	<title>Molecules, Vol. 15, Pages 8973-8987: Preparation and Properties of New Co-Crystals of Ibandronate with Gluco- or Galactopyranoside Derivatives</title>
	<link>http://www.mdpi.com/1420-3049/15/12/8973/</link>
	<description>Mixtures of ibandronate monosodium salt with eleven gluco- and/or galacto-pyranoside derivatives as counterions were designed to prepare co-crystals with improved intestinal absorption. In general, gastrointestinal absorption of bisphosphonates after oral administration is approximately 1%. Co-crystals were generated by means of thermodynamically and/or kinetically controlled crystallization processes. Seventy-seven prepared samples were analyzed by means of FT-NIR, FT-Raman spectrometry and solid state NMR spectroscopy. New entities of ibandronate monosodium salt with phenyl-β-d-galactopyranoside were found and characterized. The absorption of these potential new co-crystals was investigated by means of PAMPA experiments. In the present study the relationships between the chemical structures of the studied compounds required for co-crystal generation are discussed.</description>
	
	<guid>http://www.mdpi.com/1420-3049/15/12/8973/</guid>
	<pubDate>Wed, 08 Dec 2010 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2010-12-08</prism:publicationDate>
	<prism:volume>15</prism:volume>
	<prism:number>12</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>8973</prism:startingPage>
		<prism:endingPage>8987</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Preparation and Properties of New Co-Crystals of Ibandronate with Gluco- or Galactopyranoside Derivatives</dc:title>
	<dc:date>2010-12-08</dc:date>
	<dc:identifier>doi: 10.3390/molecules15128973</dc:identifier>
		<dc:creator>Zbynek Oktabec</dc:creator>
		<dc:creator>Jiri Kos</dc:creator>
		<dc:creator>Zuzana Mandelova</dc:creator>
		<dc:creator>Lenka Havelkova</dc:creator>
		<dc:creator>Tomas Pekarek</dc:creator>
		<dc:creator>Anna Rezacova</dc:creator>
		<dc:creator>Lukas Placek</dc:creator>
		<dc:creator>Marcela Tkadlecova</dc:creator>
		<dc:creator>Jaroslav Havlicek</dc:creator>
		<dc:creator>Jiri Dohnal</dc:creator>
		<dc:creator>Josef Jampílek</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/15/6/4283/">
	<title>Molecules, Vol. 15, Pages 4283-4293: Bisbenzamidines as Antifungal Agents. Are Both Amidine Functions Required to Observe an Anti-Pneumocystis carinii Activity?</title>
	<link>http://www.mdpi.com/1420-3049/15/6/4283/</link>
	<description>A library of 19 novel 4-(4-phenylpiperazine-1-yl)benzamidines has been synthesized and evaluated in vitro against Pneumocystis carinii. Among these compounds, N-ethyl- and N-hexyl-4-(4-phenylpiperazine-1-yl)benzamidines emerged as the most promising compounds, with inhibition percentages at 10.0 µg/mL of 87% and 96%, respectively. Those compounds remained active at 0.1 µg/mL.</description>
	
	<guid>http://www.mdpi.com/1420-3049/15/6/4283/</guid>
	<pubDate>Fri, 11 Jun 2010 00:00:00 CEST</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2010-06-11</prism:publicationDate>
	<prism:volume>15</prism:volume>
	<prism:number>6</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>4283</prism:startingPage>
		<prism:endingPage>4293</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Bisbenzamidines as Antifungal Agents. Are Both Amidine Functions Required to Observe an Anti-Pneumocystis carinii Activity?</dc:title>
	<dc:date>2010-06-11</dc:date>
	<dc:identifier>doi: 10.3390/molecules15064283</dc:identifier>
		<dc:creator> Laurent</dc:creator>
		<dc:creator> Stanicki</dc:creator>
		<dc:creator> Huang</dc:creator>
		<dc:creator> Dei-Cas</dc:creator>
		<dc:creator> Pottier</dc:creator>
		<dc:creator> Aliouat</dc:creator>
		<dc:creator> Vanden Eynde</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>
	<item rdf:about="http://www.mdpi.com/1420-3049/15/3/1213/">
	<title>Molecules, Vol. 15, Pages 1213-1222: Molecular Recognition Studies on Naphthyridine Derivatives</title>
	<link>http://www.mdpi.com/1420-3049/15/3/1213/</link>
	<description>The association constants Kb of three hosts I–III designed to have both enhanced hydrogen bonding donor strength and conformational preorganization with biotin analogues 1–5 are reported. 1H-NMR titrations under two different concentration conditions have been employed to determine the association constants Kb. A statistical analysis using a presence absence matrix has been applied to calculate the different contributions. Hydrogen bond interactions make naphthyridine derivatives II and III potent binders and effective receptors for (+)-biotin methyl ester (1), due to the complex stabilization by additional hydrogen bonds.</description>
	
	<guid>http://www.mdpi.com/1420-3049/15/3/1213/</guid>
	<pubDate>Wed, 03 Mar 2010 00:00:00 CET</pubDate>
	
	<prism:publicationName>Molecules</prism:publicationName>
	<prism:publicationDate>2010-03-03</prism:publicationDate>
	<prism:volume>15</prism:volume>
	<prism:number>3</prism:number>
	<prism:section>Article</prism:section>
	<prism:startingPage>1213</prism:startingPage>
		<prism:endingPage>1222</prism:endingPage>
		<prism:issn>1420-3049</prism:issn>
	
	<dc:title>Molecular Recognition Studies on Naphthyridine Derivatives</dc:title>
	<dc:date>2010-03-03</dc:date>
	<dc:identifier>doi: 10.3390/molecules15031213</dc:identifier>
		<dc:creator>José Carlos Iglesias-Sánchez</dc:creator>
		<dc:creator>Dolores Santa María</dc:creator>
		<dc:creator>Rosa M. Claramunt</dc:creator>
		<dc:creator>José Elguero</dc:creator>
	
	<cc:license rdf:resource="http://creativecommons.org/licenses/by/3.0/" />
</item>


<cc:License rdf:about="http://creativecommons.org/licenses/by/3.0/">
	<cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
	<cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
</cc:License>

</rdf:RDF>
